Epidemiological investigations of the respiratory tract bacteriology in patients with cystic fibrosis.
D000293:Adolescent; D001419:Bacteria / Q000302:isolation & purification*; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000382:microbiology* / Q000628:therapy; D004926:Escherichia coli / Q000302:isolation & purification; D005500:Follow-Up Studies; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D007709:Klebsiella / Q000302:isolation & purification; D011511:Proteus / Q000302:isolation & purification; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification; D012138:Respiratory Therapy; D012141:Respiratory Tract Infections / Q000382:microbiology*; D013183:Sputum / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification; D013449:Sulfonamides / Q000627:therapeutic use; D013997:Time Factors; D014132:Trachea / Q000382:microbiology
D013449:Sulfonamides